Search

Discusses the plans of Anglo American PLC to provide AIDS drugs to its African workers.

Discusses alliances between biotechnology firms and nonprofits in the United States and India, to produce inexpensive AIDS vaccines for developing countries. Efforts to avoid patent infringement in the developed world; Efforts by the International AIDS Vaccine Initiative (IAVI) to transfer technology of U.S. firm Therion Biologics Inc. to Indian vaccine maker Serum Institute of India Ltd.; Other potential partnerships.

Covers the actions taken by the Treatment Action Campaign, a South African organization, against the high cost of AIDS therapies.

Reports that United Nations Secretary-General Kofi Annan will launch a campaign to reduce prices of AIDS drugs in developing countries.

Reports that more drug-resistant strains of HIV, the AIDS disease virus, are being spread from person to person, according to researchers at a major AIDS conference in Chicago, Illinois in January 2001.

Focuses on studies on treatment interruption among AIDS patients.

Reports on the changes in the AIDS prevention strategy of the United States Centers for Disease Control.

Reports the plans of a research group in the United States to delay the treatment of AIDS patients.

Discusses the effort of Glaxo Wellcome PLC to block competition for its anti-AIDS drug Combivir in Ghana. Comments from Christopher Kiige of the African Regional Industrial Property Organization; HIV infections in sub-Saharan Africa; Agreement on pricing among pharmaceutical companies.

Discusses the problems facing doctors and hospitals in Congo due to civil war there as of December 1, 2000. Use of makeshift supplies and herbal remedies by Jean-Martin Malaba, a doctor in Congo; How international aid is not available due to the conflict.

Reports on the success of a vaccine for the Ebola virus in monkeys. Lack of a market for an Ebola vaccine, which may cause it not to be developed by pharmaceutical companies; How potential benefits of the vaccine are outweighed by the cost; Use of Ebola in bioterrorism, which may cause the vaccine to be produced.

Focuses on an agreement between several drug companies and the Senegal government on HIV drug price reductions which was reached at an October 2000 meeting in Cairo, Egypt. Background on the price-cut agreement between the Joint United Nations Programme on AIDS and drug companies; Details on the discount plans of drug companies; Significance of the agreement.

Reports on the development of a possible vaccine for the AIDS virus. Development of the vaccine by Harvard University scientists; Tests of the vaccine on monkeys who did not become sick when infected with the virus; Details of how the vaccine works by priming the immune system to control the virus rather than repelling it; Concern as to the lasting effect of the vaccine.

Details the study published in the periodical `Nature' in September 2000 which offers a promise of long-term therapy for HIV infected patients. Implications of the results of the study; Discussion on the results of the study; HIV treatment.

Reports on an AIDS treatment study that allows the human immune system to fight off the virus. Study by Bruce Walker at Massachusetts General Hospital in Boston, where recently infected HIV patients were treated with drugs and then stopped using them; Opinion that this study shows an HIV vaccine might be possible; Appearance of the study in the September 2000 edition of 'Nature.'

The article reports that Laura Silsby and 9 other U.S. missionaries have been charged by Haitian authorities with abducting 33 children. Although the missionary's position is that she was merely trying to help youth made orphans by an earthquake, at least some of them are said to have been given up by their parents. Difficulties Silsby has encountered with her previous charitable efforts are described.

The article discusses two separate studies conducted by researchers at the University of Washington International Clinical Research Center and the U.S. Centers for Disease Control and Prevention on the effectiveness of AIDS drugs marketed by Gilead Sciences Inc. to block HIV infection.

Considers the lack of health-care workers willing to treat AIDS patients in the developing world. Impact of a serious shortage of trained doctors, nurses and healthcare workers on the distribution of antiviral drugs in poor countries hard-hit by the epidemic; Examples of such countries as Cambodia, China, and Vietnam; Efforts by desperate patients to self-treat and under-medicate; Reasons for the shortage of health-care professionals in these regions; Lack of coordination and funding in getting doctors into developing countries from such places as the United States. INSET: Pitching In.

Reports that the United States Federal Bureau of Investigation is making military laboratories the focus of its anthrax investigation.

Reports on the findings of investigations on the source of the anthrax virus in the United States.

Reports on the findings of investigations on the death of Ottilie Lundgren in New Jersey in November 2001 on how she could have contracted the anthrax disease.

Reports on the investigation into how Ottilie Lundgren, a victim of inhalation anthrax, contracted the illness.

The article discusses evidence compiled by the U.S. Federal Bureau of Investigation (FBI) that it claims implicated scientist Bruce E. Ivins in a series of anthrax attacks in the U.S. Ivins wrote emails employing language similar to that of notes sent to certain victims, and also had access to the particular strain of anthrax used in the attacks. Ivins killed himself in July, 2008.

The article reports on espionage charges filed against 11 Russians in the U.S. who allegedly use their jobs and Facebook friends to act as citizens including Mikhail Semenko, Vicky Pelaez and Anna Chapman.

The article reports on the decision of Haiti to allow adoption of orphans, as it continued its child-trafficking investigation of 10 U.S. missionaries for allegedly attempting to ferry 33 children out of the nation.

Reports that tests showing a genetic link between the anthrax used in an Army program and the series of anthrax attacks in the United States has advanced the domestic-terrorism theory.

Focuses on the profile of the anthrax perpetrator that was released by the United States Federal Bureau of Investigation (FBI). Focus on a reclusive, science-minded criminal; Similarities to Theodore Kaczynski, the so-called Unabomber; Brief details of the FBI investigation; Why mounting evidence has made the lone domestic terrorist the leading theory; Background on the anthrax scare; Clues which came from the anthrax letters; Comments of experts; Continued hunt for an al Qaeda link.

Reports on the investigations conducted by the United States government on the connection of the anthrax mailings with the September 11, 2001 terrorist attack.